TaeHwan Kim - Kolon Life President
| 102940 Stock | KRW 20,350 980.00 5.06% |
Insider
TaeHwan Kim is President of Kolon Life Science
| Age | 73 |
| Phone | 82 2 3677 4150 |
| Web | https://www.kolonls.co.kr |
Kolon Life Management Efficiency
The company has return on total asset (ROA) of (0.0218) % which means that it has lost $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.822) %, meaning that it generated substantial loss on money invested by shareholders. Kolon Life's management efficiency ratios could be used to measure how well Kolon Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Dae Son | HLB Pharmaceutical Co | 46 | |
| Heo Jun | Sam A Pharm Co | 52 | |
| ShinJun Kang | Sam A Pharm Co | 58 | |
| Jeong Yoo | HLB Pharmaceutical Co | 48 | |
| Yong Cho | HLB Pharmaceutical Co | 53 | |
| KyungII Kim | Aminologics CoLtd | 65 | |
| JungBok Yoo | HLB Pharmaceutical Co | 57 | |
| YoonWoo Lee | Daihan Pharmaceutical CoLtd | 79 | |
| KukHwan Choi | Sam A Pharm Co | 59 | |
| HyeongCheol Nam | Sam A Pharm Co | 63 | |
| JongBin Kim | HLB Pharmaceutical Co | 67 | |
| Yeong Jeon | HLB Pharmaceutical Co | 45 | |
| HunYeol Yun | Aminologics CoLtd | 61 | |
| Jae Noh | HLB Pharmaceutical Co | 43 | |
| InJoong Yoon | Choong Ang Vaccine | 61 | |
| Dong Lee | HLB Pharmaceutical Co | 51 | |
| WonSup Kim | Aminologics CoLtd | 64 | |
| DongYeop Lee | HLB Pharmaceutical Co | 60 | |
| JaeGwan Lee | Aminologics CoLtd | 64 | |
| WanJoo Kim | HLB Pharmaceutical Co | N/A | |
| Jeong Yoon | HLB Pharmaceutical Co | 49 | |
Management Performance
| Return On Equity | -6.82 | |||
| Return On Asset | -0.0218 |
Kolon Life Science Leadership Team
Elected by the shareholders, the Kolon Life's board of directors comprises two types of representatives: Kolon Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kolon. The board's role is to monitor Kolon Life's management team and ensure that shareholders' interests are well served. Kolon Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kolon Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| WooSok Lee, Chief Officer | ||
| SangWoo Lee, Managing Management | ||
| SangJun Lee, Chief VicePres | ||
| MunHee Park, Chief Officer | ||
| SangHu Park, Managing Director | ||
| TaeHwan Kim, President | ||
| MyungKwan Suh, Managing Division |
Kolon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kolon Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.82 | |||
| Return On Asset | -0.0218 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 437.45 B | |||
| Shares Outstanding | 11.41 M | |||
| Shares Owned By Insiders | 35.61 % | |||
| Price To Earning | 286.10 X | |||
| Price To Sales | 3.32 X | |||
| Revenue | 165.49 B |
Pair Trading with Kolon Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kolon Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kolon Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Kolon Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kolon Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kolon Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kolon Life Science to buy it.
The correlation of Kolon Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kolon Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kolon Life Science moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kolon Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Kolon Stock
Kolon Life financial ratios help investors to determine whether Kolon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kolon with respect to the benefits of owning Kolon Life security.